2011
Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on Blood Glucose Levels in Diabetic and Nondiabetic Patients in General Clinical Practice, Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffrey Sivik D Pharma; and Joseph J. Drabick MD, FACP (Article)
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)., Kenneth I Ataga, Marvin Reid, Samir K Ballas, Zahida Yasin, Carolyn Bigelow, Luther St James, Wally R Smith, Frederic Galacteros, Abdullah Kutlar, James H Hull, Jonathan W Stocker, and Maged Khalil MD (Article)
Large vocal fold polyp., Venu Divi, Robert T Sataloff, and Jacqueline Oxenberg DO (Article)
Mid-term Analysis of IIIA NSCLC Patients Treated With Neoadjuvant Chemoradiation Followed by Surgical Resection, Eliot L. Friedman MD (Presentation)
Neo-adjuvant Chemotherapy and Radiation Therapy in Patients with Stage IIIA (N2) Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis with Lessons Learned, Eliot L. Friedman MD, Michael F. Szwerc MD, Charles Andrews MD, Robert Kruklitis MD, Kathleen A. Leies, and Ferdy Santiago (Poster)
PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations., Farzaneh Ghazavi, Zeinab Fazlali, Setareh Sadat Banihosseini, Sayed-Rzgar Hosseini, Mohammad Hossein Kazemi MD, Seyedmehdi Shojaee, Khosro Parsa, Homa Sadeghi, Farzad Sina, Mohammad Rohani, Gholam-Ali Shahidi, Nasser Ghaemi, Mostafa Ronaghi, and Elahe Elahi (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives—Year 1 NCCCP at Lehigh Valley Health Network, Gregory R. Harper MD, PhD; Ada M. Rivera BA; Eliot L. Friedman MD; Kathleen A. Leies RN, OCN; Nadesda Mack RN, BSN, MBA, OCN; Lenore McGonigle Med; Suresh G. Nair MD; Tara Namey MS, CGC; Debbie Salas-Lopez MD, MPH, FACP; and Ronald W. Swinfard MD, FACP (Poster)
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse., Maciej Kmieciak, Debasmita Basu, Kyle K Payne, Amir Toor MD, Adly Yacoub, Xiang-Yang Wang, Lisa Smith, Harry D Bear, and Masoud H Manjili (Article)
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation., Maciej Kmieciak, Amir Toor MD, Laura Graham, Harry D Bear, and Masoud H Manjili (Article)
Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses"., Masoud H Manjili and Amir Toor MD (Article)
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222., Heidi Mc Kean, Philip J Stella, Shauna L Hillman, Kendrith M Rowland, Michael W Cannon, Robert J Behrens, Gerald G Gross, Mark D Sborov, Eliot L. Friedman MD, and Aminah Jatoi (Article)
2010
Effect of the Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib, Dasatinib, and Imatinib) on Blood Glucose Levels in Diabetic and Non-diabetic Patients in General Clinical Practice (Poster), Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffery Sivik D Pharma; and Joseph J. Darbick MD, FACP (Poster)
Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature, Nicole M. Agostino DO and Rebecca Gingrich (Article)
The role of CD40L and VEGF in the modulation of angiogenesis and inflammation., Subrata Chakrabarti, Muhammad A. Rizvi MD, Kristine Morin, Ravi Garg, and Jane E Freedman (Article)
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients with Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326., Grace K. Dy, Shauna L. Hillman, Kendrith M. Rowland, Julian R. Molina, Preston D. Steen MD, Donald B. Wender, Suresh G. Nair MD, Sumithra Mandrekar, Steven E. Schild, and Alex A. Adjei (Article)
Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases., Michael W. Evans MD, MPH; Leroy B Vaughan; Victoria S Giffi; Ann B Zimrin; and John R Hess (Article)
Multidisciplinary Survivorship Care, Sue N. Gardner RN, MSN, CRNP, AOCNP; Gregory Harper MD, PhD; Dorothy Morrone RNC, MS, OCN; Jennifer Brennan RD, CSO; Andrea Geshan RN, MSW; Diane Brong LCSW; and Jennifer Roeder MSPT, MBA (Poster)
Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation., Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor MD, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, and Patrick Stiff (Article)
Primary Merkel cell carcinoma of the parotid gland., Mahmoud Ghaderi, Jeffrey Coury, Jacqueline Oxenberg DO, and Harvey Spector (Article)
Cancer: The Lived Experience of Patients and Families, Lorraine Gyauch MA, RN,CT, CGS (Presentation)
Incorporating Rehabilitation Services into Oncology Site-specific Clinical Practice Guidelines, Kathleen Leies RN, OCN; Kathy Sevedge RN, MA, AOCN; Dorothy Morrone RNC, MS, OCN; Stephanie Marshall CCER; and Jennifer Roeder MSPT, MBA (Poster)
Immunologic Therapy with Cadi-05 for the Treatment of Advanced Melanoma, Paul J. Mosca MD, PhD; Suresh G. Nair MD; Susan K. Ayre RN, MA; Wenjing Shi RN, MS; Sherrine Eid MPH; Shantu Amin PhD; Dhimant Desai PhD; Joseph J. Drabick MD, FACP; Bakulesh M. Khamar MD; Arati Sharma PhD; Svetomir N. Markovic MD; and Gavin P. Robertson PhD (Poster)
Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147, Suresh G. Nair MD; Richard M. Goldberg; Daniel J. Sargent; Stephen N. Thibodeau; Margaret R. Mahoney; Anthony F. Sheilds; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; and Steven R. Alberts MD, MPH (Presentation)
RB gene family: genome-wide ChIP approaches could open undiscovered roads., Flavio Rizzolio, Luca Esposito, Debora Muresu, Roberto S Fratamico MD, Ranna Jaraha, Gianluca Vosa Caprioli, and Antonio Giordano (Article)
Identification of Issues Faced by Cancer Survivors, Kathy Sevedge RN, MA, AOCN (Poster)
Patient Navigation: Past, Present and Future, Kathy Sevedge RN, MA, AOCN (Presentation)
2009
Training Tomorrow’s Providers and Expanding Access to Peginterferon/Ribavirin Combination Therapyfor Chronic Hepatatis C in Underinsured/Uninsured Patients: Final Outcomes of a Pilot, Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Suzanne J. Templer DO; Edward Norris MD, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Hypoxia influences CD40-CD40L mediated inflammation in endothelial and monocytic cells., Subrata Chakrabarti, Muhammad A. Rizvi MD, Didi Pathak, Michael T Kirber, and Jane E Freedman (Article)
Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding., Hongan Le, Sheetal Singh, Shyh-Jen Shih, Nga Du, Sabine Schnyder, Grace A Loredo, Christine Bien, Laura Michaelis, Amir Toor MD, Manuel O Diaz, and Andrew T Vaughan (Article)
Acute Splenic Infarct in Beta-Thalassemia Minor: A Novel Combination of Heterozygous Beta-Globin Mutations With Latent Phenotypes and the Clinical Implications, Danny C. Liaw, Adam J. Kotkiewicz, and Mark A. Kender (Article)
Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism., Sonyo Shin, Takayuki Asano, Yixin Yao, Ronghua Zhang, Francois-Xavier Claret, Murray Korc, Kanaga Sabapathy, David G Menter, James L Abbruzzese, and Shrikanth A G Reddy (Article)
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same., Amir Toor MD (Article)
Impaired NHEJ function in multiple myeloma., Clara Yang, Christopher Betti, Sheetal Singh, Amir Toor MD, and Andrew Vaughan (Article)
2008
Psychiatric Outcomes in a Resident-Run Multidisciplinary Hepatitis C Clinic, Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases., Sheikh Asim Ali MD, Wassim M McHayleh, Asif Ahmad, Rajesh Sehgal, Molly Braffet, Mohsin Rahman, Ghassan Bejjani, and David M Friedland (Article)
Marginal-zone B-cell lymphoma of the bony palate presenting as sinusitis., Lisa Skultety Ayers, Jacqueline Oxenberg DO, Seth Zwillenberg, and Mahmoud Ghaderi (Article)
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177., Paul D Brown, Sunil Krishnan, Jann N Sarkaria, Wenting Wu, Kurt A Jaeckle, Joon H Uhm, Francois J Geoffroy, Robert Arusell, Gaspar Kitange, Robert B Jenkins, John W Kugler, Roscoe F Morton, Kendrith M Rowland, Paul Mischel, William H Yong, Bernd W Scheithauer, David Schiff, Caterina Giannini, Jan C Buckner, and Suresh G. Nair MD (Article)
Can Surgeons Improve Survival in Stage IV Melanoma?, Paul J. Mosca MD, PhD; Erik J. Teicher MD; Suresh G. Nair MD; and Barbara A. Pockaj (Article)
Targeting Intracellular Signaling Pathways in Soft Tissue Sarcoma (STS)., Suresh G. Nair MD, Abhishek Sharma, and Amin S. Robertson (Poster)
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease., Muhammad A. Rizvi MD, Didi Pathak, Jane E Freedman, and Subrata Chakrabarti (Article)
Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT., Amir Toor MD, T Rodriguez, M Bauml, H Mathews, S Shanti, D Senitzer, A Kini, J Norton, M Parthasarathy, N Mohideen, C Petrowsky, B Bonilla, S Smith, and P Stiff (Article)
2007
Current Immunotherapeutic Strategies in Malignant Melanoma., Nicole Agostino DO; Arjumand Ali MD; Suresh G. Nair MD; and Paul J. Mosca MD, PhD (Article)
Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in a Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Erini Vasiliadis DO; K Nadeem Ahmed MD; Suzanne J. Templer DO; Edward R. Norris MD, FAPA, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma., Henry C Fung, Patrick Stiff, Jeff Schriber, Amir Toor MD, Eileen Smith, Tulio Rodriguez, Amrita Krishnan, Arturo Molina, David Smith, Barbara Ivers, Neil Kogut, Leslie Popplewell, Roberto Rodriguez, George Somlo, Stephen J Forman, and Auayporn Nademanee (Article)
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections., K Mullane, Amir Toor MD, C Kalnicky, T Rodriguez, J Klein, and P Stiff (Article)
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity., Amir Toor MD, Patrick J Stiff, Brian J Nickoloff, Tulio Rodriguez, Jared L Klein, and Kenneth B Gordon (Article)
Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy., Haowei Zhang, Ranju Gupta MD, Jen C Wang, Jeffrey F Lipton, and Yi-Wu Huang (Article)
2006
Psychiatric Outcomes in a Resident-run, Multidisciplinary, Hepatitis C Clinic (Poster), Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma., J Duus, H I Bahar, G Venkataraman, F Ozpuyan, K F Izban, H Al-Masri, T Maududi, Amir Toor MD, and S Alkan (Article)
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders., Ranju Gupta, Sirisha Perumandla, Yelena Patsiornik, Selvanayagam Niranjan, and Anju Ohri (Article)
A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer., Julian R. Molina, Daniel Nikcevich, Shauna L. Hillman, Susan Geyer, Timothy Drevyanko, James Jett, Joseph Verdirame, Henry Tazelaar, Kendrith M. Rowland, Edward Wos, Leila Kutteh, Suresh G. Nair MD, Tom R. Fitch, Patrick Flynn, Philip J. Stella MD, and Alex A. Adjei (Article)
Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma., Katherine E. Posther, M Angelica Selim, Paul J. Mosca, Wilma E. Stanley, Jeffrey L. Johnson, Douglas S. Tyler MD, and Hilliard F. Seigler MD (Article)
Cultural Compentency and Cancer, Debbie Salas-Lopez MD, MPH (Presentation)
The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure., Scott E Smith, Amir Toor MD, Tulio Rodriguez, and Patrick Stiff (Article)
Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation., P J Stiff, L A Miller, P Mumby, K Kiley, R Batiste, N Porter, K Potocki, M Volle, S Lichtenstein, S Wojtowicz, S Zakrzewski, Amir Toor MD, and T Rodriguez (Article)
Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis., P Stiff, P Mumby, L Miler, T Rodriguez, M Parthswarthy, K Kiley, N Porter, R Batiste, S Wojtowitz, S Lichtenstein, M Fox-Geiman, and Amir Toor MD (Article)
Cardiac nonamyloidotic immunoglobulin deposition disease., Amir Toor MD, Ben A Ramdane, Jacob Joseph, Maria Thomas, Carl O'Hara, Bart Barlogie, Patrick Walker, and Lija Joseph (Article)
Expanding Access to Care through a Resident-Initiated Hepatitis C Clinic - An Innovative Method for Incorporating ACGME Core Competencies into the Management of Medically Underserved Patients, Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Erini Vasiliadis DO; Vishal Patel MD; Nicole M. Agostino DO; K Nadeem Ahmed MD; Edward Norris MD, FAPM; Charles M. Brooks MD; and Eric J. Gertner MD, MPH (Poster)
2005
Oxaliplatin, Fluorouracil, and Leucovorin for Patients with Unresectable Liver-Only Metastases from Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study., Steven R. Alberts MD, MPH; William L. Horvath; William C. Sternfeld; Richard M. Goldberg; Michelle R. Mahoney; Shaker R. Dakhil MD; Ralph Levitt MD; Kendrith M. Rowland; Suresh G. Nair MD; Daniel J. Sargent; and John H. Donohue (Article)
Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response., Thomas A. Aloia MD; Elizabeth Grubbs MD; Mark Onaitis MD; Paul J. Mosca MD, PhD; Tsung-Yen Cheng MD; Hilliard F. Seigler MD; and Douglas S. Tyler MD (Article)
Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells., Takayuki Asano, Yixin Yao, Sonyo Shin, James McCubrey, James L Abbruzzese, and Shrikanth A G Reddy (Article)
Perceived Quality of Life Among Smokers in Smoking Cessation Therapy., I Croghan, Jeff A. Sloan, R D. Hurt, G A. Croghan, Shaker R. Dakhil MD, Paul J. Novotny, D Schroeder, Edward J. Wos, Kendrith M. Rowland, and Suresh G. Nair MD (Article)
Second allografts for relapsed hematologic malignancies: feasibility of using a different donor., J E Duus, P J Stiff, J Choi, M Parthasarathy, T Rodriguez, and Amir Toor MD (Article)
Tuberculosis of sacroiliac joint: an unusual presentation., Ranju Gupta MD, Harry Bienenstock, Placido Morano, and Anil Gupta (Article)
Should Elderly Non-Small-Cell Lung Cancer Patients be Offered ElderlySpecific Trials? Results of a Pooled Analysis from the North Central Cancer Treatment Group., Aminah Jatoi, Shauna L. Hillman, Philip J. Stella MD, Erin Green, Alex A. Adjei, Suresh G. Nair MD, Edith A. Perez MD, Bipinkur Amin, Steven E. Schild, Rene Castillo, and James R. Jett (Article)
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass., Maged Khalil MD, Padjama Sai, Zili He, Ashraf Aziz, William Steier, Shetra Sivamurthy, Ming Liu, and Madhumati Kalavar (Article)
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature., Maged Khalil MD, Asha Thomas, Adel Aassad, Moshe Rubin, and Robert N Taub (Article)
Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine as Front-Line Therapy for Advanced Non-Small-Cell Lung Cancer., Cynthia X Ma, Suresh G. Nair MD, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch MD, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, and Alex A. Adjei (Article)
Factors that Influence Colorectal Cancer Screening Practice in the Latino Community, Ana Natale-Pereira MD, MPH; Marielos Vega RN, BSN; Jonnie Marks PhD; Debbie Salas-Lopez MD, MPH; and M S. Johnson (Presentation)
Perspectives on Cancer Screening Among Internal Medicine Residents and Latino Community Members: A Work in Progress, Debbie Salas-Lopez MD, MPH; Dawne M. Mouzon MPH; Ana Natale-Pereira MD, MPH; Vincent J. Barba; John Kolassa; Jonnie Marks PhD; and Maria L. Soto-Greene MD (Presentation)
2004
Gemcitabine and ISIS-2503 for Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial., Steven R. Alberts MD, MPH; Mark Schroeder; Charles Erlichman; Preston D. Steen MD; Nathan R. Foster; Dennis F. Moore; Kendrith M. Rowland; Suresh G. Nair MD; Loren K. Tschetter; and Tom R. Fitch MD (Article)
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines., Christiane Houde, Yulin Li, Lynda Song, Kevin Barton, Qing Zhang, John Godwin, Sucha Nand, Amir Toor MD, Serhan Alkan, N Veronique Smadja, Hervé Avet-Loiseau, Carmen S Lima, Lucio Miele, and Lionel J Coignet (Article)
Investigating Four 'Myths' Surrounding Dysphagia in Patients with Metastatic Esophageal Cancer. A Multi-Institutional Study from the North Central Cancer Treatment Group., Aminah Jatoi, Nathan R. Foster, P Johnson, George G. Klee, J F Quevedo, Roscoe F. Morton MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James A. Mailliard MD (Article)
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients with Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort., Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Jeff A. Sloan, Shaker R. Dakhil MD, Neil MacDonald, Bruno Gagnon, Paul J. Novotny, James A. Mailliard MD, Teresita I L Bushey, Suresh G. Nair MD, and Brad Christensen (Article)
Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity., Anne Kanard, Aminah Jatoi, Rene Castillo, Susan Geyer, Thomas K. Schulz, Tom R. Fitch MD, Kendrith M. Rowland, Suresh G. Nair MD, James E. Krook MD, and John W. Kugler MD (Article)
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis., Maged Khalil MD, William D Wagner, and Ira J Goldberg (Article)
Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): a Trial of the Eastern Cooperative Oncology Group., Corey J. Langer, Yi Li, Timothy Jennings, Ronald C. DeConti, Suresh G. Nair MD, Roger B. Cohen, and Arlene A. Forastiere (Article)
Post-transplant air-leak syndrome., Tawee Tanvetyanon, Amir Toor MD, and Patrick J Stiff (Article)
Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma., Amir Toor MD, John Ayers, Joan Strupeck, Mala Parthasarathy, Steve Creech, Tulio Rodriguez, and Patrick J Stiff (Article)
2003
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective., Julian P Cooney, Patrick J Stiff, Amir Toor MD, and Mala Parthasarathy (Article)
Infection--an underappreciated cause of bone pain in multiple myeloma., Raman Desikan, Bart Barlogie, Rajesh Sethi, Amir Toor MD, Dan Spoon, Edward Angtuaco, Rudy Vanhemert, Anantha VijayaGopal, Seema Singhal, Jayesh Mehta, Sundar Jagannath, Nikhil Munshi, Maurizio Zangari, Athanassios Fassas, Guido Tricot, and Elias Anaissie (Article)
Impact of Immediate Reconstruction on the Local Recurrence of Breast Cancer After Mastectomy., Robert X. Murphy JR, MD, MS; Samina Wahhab MD; Peter Rovito MD; Gregory R. Harper MD, PhD; Sharon R. Kimmel; Lawrence C. Kleinman MD, MPH; and Mark J. Young MD (Article)
2002
CPT-11 for Bile-Duct and Gallbladder Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Study., Steven R. Alberts MD, MPH; Paul A. Fishkin; Lawrence J. Burgart; Peter J. Cera; Michelle R. Mahoney; Roscoe F. Morton MD; Patricia A. Johnson; Suresh G. Nair MD; and Richard M. Goldberg (Article)
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning., Ashraf Badros, Guido Tricot, Amir Toor MD, Christopher Morris, Chuanfa Guo, Nikhil Munshi, Bart Barlogie, and Michele Cottler-Fox (Article)
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations., Athanasios B-T Fassas, Firas Muwalla, Tanya Berryman, Riad Benramdane, Lija Joseph, Elias Anaissie, Rajesh Sethi, Raman Desikan, David Siegel, Ashraf Badros, Amir Toor MD, Maurizio Zangari, Christopher Morris, Edgardo Angtuaco, Sajini Mathew, Carla Wilson, Aubrey Hough, Sami Harik, Bart Barlogie, and Guido Tricot (Article)
Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients with Colon Carcinoma: A 10-Year Experience of the Geisinger Medical Center., Farid Fata, Ayoub Mirza, G Craig, Suresh G. Nair MD, Amy Law, James Gallagher, Neil Ellison, and Albert M. Bernath MD (Article)
Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer., Katherine A Harris, Elaine Harney, and Eric J Small (Article)
Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer., Katherine A Harris, Vivian Weinberg, Robert A Bok, Mika Kakefuda, and Eric J Small (Article)
A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia., Aminah Jatoi; Marisa Tria Tirona; Steven S. Cha; Steven R. Alberts MD, MPH; Kendrith M. Rowland; Roscoe F. Morton MD; Suresh G. Nair MD; Carl G. Kardinal MD; Philip J. Stella MD; James A. Mailliard MD; Daniel J. Sargent; and Richard M. Goldberg (Article)
Microscale assay for screening of inhibitory activity of Lactobacillus., Bradley Lash, Hassan Gourama, and Tami H Mysliwiec (Article)
Long-Term Survival of Patients with Advanced/Recurrent Carcinoma of Cervix and Vagina After Neoadjuvant Treatment with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the Addition of Molgramostim, and Review of the Literature., Harry J. Long, Sandra Rayson, Karl C. Podratz, Samir Abu-Ghazaleh, Vera J. Suman PhD, Lynn C. Hartmann MD, Ralph Levitt MD, Suresh G. Nair MD, Alan K. Hatfield MD, and James A. Knost (Article)
Tissue-specific effects of chronic dietary leucine and norleucine supplementation on protein synthesis in rats., Christopher J Lynch, Susan M Hutson, Brian J. Patson MD, Alain Vaval, and Thomas C Vary (Article)
A phase II study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancer., Randolph S. Marks MD and Suresh G. Nair MD (Article)
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study., David J Moliterno, Steven J Yakubov, Peter M DiBattiste, Howard C Herrmann, Gregg W Stone, Carlos Macaya, Franz-Josef Neumann, Diego Ardissino, Jean-Pierre Bassand, Lynn Borzi, Alan C Yeung, Katherine A Harris, Laura A Demopoulos, and Eric J Topol (Article)
Clinical activity of arsenic trioxide for the treatment of multiple myeloma., N C Munshi, G Tricot, R Desikan, A Badros, M Zangari, Amir Toor MD, C Morris, E Anaissie, and B Barlogie (Article)
Women Experience Greater Toxicity with Fluorouracil-Based Chemotherapy for Colorectal Cancer., Jeff A. Sloan, Richard M. Goldberg, Daniel J. Sargent, Delfino Vargas-Chanes, Suresh G. Nair MD, Steven S. Cha, Paul J. Novotny, Michael A. Poon, Michael J. O'Connell, and Charles L. Loprinzi (Article)
Secondary hormonal manipulation of prostate cancer., Eric J Small and Katherine A Harris (Article)
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients., Amir Toor MD, A Slungaard, U Hedner, D J Weisdorf, and N S Key (Article)
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants., Guido Tricot, Trey Spencer, Jeffrey Sawyer, Dan Spoon, Raman Desikan, Athanasios Fassas, Ashraf Badros, Maurizio Zangari, Nikhil Munshi, Elias Anaissie, Amir Toor MD, and Bart Barlogie (Article)
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications., M Zangari, F Saghafifar, E Anaissie, A Badros, R Desikan, A Fassas, P Mehta, C Morris, Amir Toor MD, D Whitfield, E Siegel, B Barlogie, L Fink, and G Tricot (Article)